Form 4 for MRNA Moderna
Accepted 2026-09-03 16:56:28 ET · period of report 2026-09-01 · accession 0001682852-26-000167 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DMT | 2026-09-03 16:56 | 2026-09-01 | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | $30.96 | +5,637 | 76.3K | +8% | +$174.5K |
| DT | 2026-09-03 16:56 | 2026-09-01 | MRNA | Klinger Shannon Thyme | CLO | S - Sale+OE | $139.95 | -3,471 | 74.1K | -4% | -$485.8K |
| DT | 2026-09-03 16:56 | 2026-09-01 | MRNA | Klinger Shannon Thyme | CLO | F - Tax | $140.34 | -1,048 | 75.2K | -1% | -$147.1K |
| DMT | 2026-09-03 16:56 | 2026-09-01 | MRNA | Klinger Shannon Thyme | CLO | M - OptEx | $0.00 | -5,637 | 21.7K | -21% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-09-01 | M | A | 3,471 | $30.96 | 77,600 | D | — | — | (F1) The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on September 9, 2025. |
| 2 | Common | Common Stock | 2026-09-01 | S | D | 3,471 | $139.95 | 74,129 | D | — | — | (F1) The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on September 9, 2025. |
| 3 | Common | Common Stock | 2026-09-01 | M | A | 2,166 | — | 76,295 | D | — | — | (F2) Restricted stock units convert into common stock on a one-for-one basis. (F2) Restricted stock units convert into common stock on a one-for-one basis. |
| 4 | Common | Common Stock | 2026-09-01 | F | D | 1,048 | $140.34 | 75,247 | D | — | — | (F3) Represents shares withheld at the election of the Reporting Person to satisfy tax withholding obligations in connection with the vest of restricted stock units. |
| 5 | Derivative | Stock Option (Right to Buy) | 2026-09-01 | M | D | 3,471 | $0.00 | 34,716 | D | $30.96 · 2026-03-01 to 2035-03-01 | 3,471 Common Stock | (F1) The reported transaction was effected pursuant to a Rule 10b5-1 trading plan adopted on September 9, 2025. (F4) 25% of this option vested and became exercisable on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |
| 6 | Derivative | Restricted Stock Units | 2026-09-01 | M | D | 2,166 | $0.00 | 21,661 | D | — · — to — | 2,166 Common Stock | (F2) Restricted stock units convert into common stock on a one-for-one basis. (F2) Restricted stock units convert into common stock on a one-for-one basis. (F5) 25% of the shares subject to this restricted stock unit award vested on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter. (F5) 25% of the shares subject to this restricted stock unit award vested on March 1, 2026 with the remainder vesting in twelve (12) equal quarterly installments thereafter. |